Delivery of miR‐23b‐3p into the ventricles of APP/PS1 mouse brains can improve their cognitive deficits, alleviate AD pathology, and especially reduce tau phosphorylation at multiple sites. This evidence concerns the gene APP and Alzheimer disease.